Crumly & Associates Inc. Astrazeneca PLC Transaction History
Crumly & Associates Inc.
- $323 Million
- Q4 2024
A detailed history of Crumly & Associates Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Crumly & Associates Inc. holds 7,083 shares of AZN stock, worth $539,016. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,083
Previous 6,644
6.61%
Holding current value
$539,016
Previous $517,000
10.25%
% of portfolio
0.14%
Previous 0.16%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.59 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.12 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.85 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.82 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.83 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $236B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...